Primary Care Focus Is Key To Bayer's Leading Position In China
This article was originally published in PharmAsia News
Executive Summary
Bayer Schering Pharma didn't become the number one healthcare company in China simply through the merger of Bayer and compatriot Schering AG in 2006. "The pure act of merging would not have been enough; we would only have been number six" in China, explains Liam Condon, managing Director of Bayer HealthCare China, which reported 2008 sales of over $750 million and over 50 percent growth